Company / Operating Margin
BIOCRYST PHARMACEUTICALS INC Operating Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-228.0%
FY2017
5-year range
-
FY2016-FY2017
Trend
-23.6%
vs FY2016
Sector context
#102 of 135
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's operating margin of -228.0% is lower than 76% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
-228.0% in FY2017.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 135This company -228.0% Sector average -774.4%
▼
+70.6% above sector average
Key checks
Key Insights
- In FY2017, operating margin decreased 23.6% year-over-year.
- Currently 546.5pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -228.0% | -23.6% |
| FY2016 | -184.4% | -125.7% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026